Literature DB >> 26025416

Yessotoxin activates cell death pathways independent of Protein Kinase C in K-562 human leukemic cell line.

Andrea Fernández-Araujo1, Amparo Alfonso1, Mercedes R Vieytes2, Luis M Botana3.   

Abstract

Protein Kinase C (PKC) is a group of enzymes involved in pro-survival or pro-apoptotic events depending on the cellular model. Moreover, Yessotoxin (YTX) modulates its expression and activates different cell death pathways. In K-562 tumor cell line, YTX induces apoptosis and autophagy after 24 and 48 h of incubation, respectively, and the toxin carries out its action through the phosphodiesterase 4A (PDE4A). Therefore, the levels of two subtypes of PKC, conventional (cPKC) and δ isotype of novel PKC (PKCδ) were studied at these times after YTX incubation. Also their involvement in the cell death activated by the toxin and their relationship with PDE4A was checked. The expression of cPKC and PKCδ in cytosol, plasma membrane and nucleus was studied in normal and PDE4A-silenced cells. Furthermore, cell viability of normal cells, as well as cPKC-, PKCδ- and PDE4A-silenced cells was tested by Lactate Dehydrogenase (LDH) assay. As a result, PKCδ showed a key role in K-562 cell survive, since without this protein, K-562 cell decreased their viability. Furthermore, modulation of PKCs by YTX treatment was observed, however, the changes in the expression of these proteins are independent of cell death activated by the toxin. In addition, the modulation of PKCs detected is PDE4A-dependent, since the silencing of this protein change PKC expression pattern.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PDE4A; PKC delta; Viability; YTX; cPKC

Mesh:

Substances:

Year:  2015        PMID: 26025416     DOI: 10.1016/j.tiv.2015.05.013

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  2 in total

1.  aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1.

Authors:  Li Tian; Yun Lu; Tao Yang; Zhengdong Deng; Lei Xu; Wei Yao; Chaoqun Ma; Xiangyu Li; Jian Zhang; Yan Liu; Jianming Wang
Journal:  Redox Biol       Date:  2019-02-21       Impact factor: 11.799

Review 2.  Yessotoxin, a Promising Therapeutic Tool.

Authors:  Amparo Alfonso; Mercedes R Vieytes; Luis M Botana
Journal:  Mar Drugs       Date:  2016-01-28       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.